Roche’s Alzheimer’s drug fails to meet primary target
Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials
Drugs
Pharma
Drugs
Pharma
Medicines to treat drug-resistant TB highly expensive for poor patients
With newer TB drugs to go off patent in 2023, MSF calls on J&J, Otsuka, to lower pricing barriers and allow generic manufacturers.
Drugs
Pharma
Sanofi signs $1.2 billion drug discovery agreement with Insilico
Sanofi signs $1.2 billion drug discovery deal with AI driven drug startup Insilico
Drugs
Pharma
Nitta Gelatin approves INR 1.1 billion expansion plan
The board of directors of Nitta Gelatin India has approved an INR 1.1 billion expansion plan, according to a BSE filing.
Drugs
Health
Pharma
Global vaccine market remains ‘highly concentrated’
Global vaccine distribution has been inequitable, and vaccines that have been prioritised by the WHO does not see the light of the day,.
Drugs
Health
Pharma
Viatris acquires two companies for $750 million to sharpen ophthalmology vision
Viatris acquires two companies for $750 million to fuel ophthalmology vision
Drugs
Pharma
Cipla’s board rejects plan to transfer US-based operations
HQ Team November 4, 2022: The management of Cipla, an Indian drug maker, has rejected a plan to transfer its US-based operations based.
Health
Pharma
Ebola outbreak in Uganda spreads to new districts
An Ebola outbreak in Uganda has spread to seven districts, according to the World Health Organisation.
Drugs
Pharma
Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Drugs
Pharma
Diabetes, obesity drugs boost Novo Nordisk profit, sales
Novo Nordisk net profit rose 14% year-on-year in nine months to September as it forecasted higher profit and sales for the year on.